ArticleJournal of hepatocellular carcinoma2025
Screening Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Patients After Tyrosine Kinase Inhibitor Plus PD-1/PD-L1 Antibody Therapy: A Multicenter Retrospective Study.
Zhe Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.